Viewing Study NCT01767792


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-02-22 @ 9:36 AM
Study NCT ID: NCT01767792
Status: COMPLETED
Last Update Posted: 2021-02-12
First Post: 2013-01-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Sponsor: University of Alabama at Birmingham
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neurofibromatosis Type 2 View
None Progressive Vestibular Schwannomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neurofibromatosis Type 2 View
None Progressive Vestibular Schwannomas View